If you’re having trouble controlling your diabetes, consider participating in HARMONY, a clinical research study evaluating an investigational diabetes medication that’s taken only once a week.

It’s estimated that 50% of diabetics in the U.S. struggle to successfully control their blood sugar. The inconvenience of multiple daily treatments can often add to this struggle. Now, the HARMONY program is evaluating the effectiveness of an investigational, long-acting type 2 diabetes medication which may require less frequent dosing.

An increasing number of people are being diagnosed with diabetes, and more effective treatments are needed. Qualified participants will receive study treatment as well as study-related medical evaluations and tests at no cost.

Clinical Research of West Florida is currently looking for people with Type 2 Diabetes to take part in a research study of an investigational drug for the treatment of diabetes.

If you are 18 or older and currently not taking any diabetic medications, we would like to hear from you. All qualified participants may receive study related medical care, study medication as well as reimbursement for travel expenses.

For more information, or to see if you qualify, please call 813-870-1292 For more information, call Clinical Research of West Florida at 813-870-1292 or email us at research@crwf.com.

Clinical Research of West Florida is currently testing an approved medication for the treatment of high blood pressure. Study participants must be at least 18 years old, be Type II Diabetic, and have a diagnosis of high blood pressure.

Study medication and study-related care will be provided under the direct supervision of a physician. Compensation for time and travel may be provided.

Please call 813-870-1292 or email us at research@crwf.com for more information.

If so, you may qualify for a clinical research study of an approved oral pain medication being evaluated for the treatment of chronic pain.

If you qualify, you will receive study medication, study-related medical care and compensation for travel.

For more information, call Clinical Research of West Florida at 813-870-1292 or email us at research@crwf.com.

If you suffer from this condition, known as postherpetic neuralgia, you may qualify to participate in a research study being conducted in the Tampa Bay area.

Qualified participants must be at least 18 years of age and will receive study medication, study-related exams, and compensation for time and travel.

If you have pain from your shingles please call 813-870-1292 or email us at research@crwf.com.

If so, you may qualify for a clinical research study of an approved oral pain medication being evaluated for the treatment of acute low back pain.

If you qualify, you will receive study medication, study-related medical care and compensation for travel.

For more information, call Clinical Research of West Florida at 813-870-1292 or email us at research@crwf.com.

We are conducting a clinical research study looking at whether an investigational medication is safe and effective in treating constipation that commonly occurs in people taking opioid pain medications, like morphine.

You may be able to participate if you are:

• 18 to 84 years of age
• Taking at least one prescription opioid pain medication daily
• Experiencing moderate-to-severe constipation symptoms even after using a laxative for at least 4 days, such as:
  • Fewer than three bowel movements per week
  • Hard/lumpy stools
  • Straining sensation of incomplete bowel movement

The KODIAC Study will last for about 18 weeks and will require nine visits to the study center so that the study doctors and nurses can perform tests and monitor your health.

For more information, call Clinical Research of West Florida at 813-870-1292 or email us at research@crwf.com.

CRWF is dedicated to providing excellent patient care, while conducting innovative clinical research studies.
CRWF has an exemplary staff comprised of 15 board eligible/certified physicians, 13 trained clinical study coordinators, two ARNPs, two regulatory managers, two laboratory manager, and additional office support staff.

We invite you to browse through our website to learn more about CFWF and our currently enrolling clinical studies!

To pre-qualify for this study, you must:

• Be 18 years or older
• Have confirmed diagnosis of Crohn’s Disease
• Have Crohn’s Disease symptoms for at least 3 months

Study participants will receive:

• Study drug at no cost
• Study-related medical exams and blood tests
• Compensation for time and travel

To take part of our Tampa Crohn’s Disease Clinical Research Study, apply today! For more information, call Clinical Research of West Florida at 727-466-0078 or email us at research@crwf.com.

About Lupus

More than two million individuals in North America have systemic lupus erythematosus (SLE). SLE can occur at any age in either sex. Among adults with SLE, women are 10-15 times more likely to be affected than adult men.

Symptoms

• Achy and swollen joints
• Fever more than 100 degrees (F)
• Prolonged or extreme fatigue
• Rash or lesions

Treatment

• NSAIDS, nonsteroidal anti-inflammatory drugs, are used to relieve achy joints and arthritis in SLE when pain is limited and organs are not affected.
• Antimalarial drugs, such as hydroxycholoquine, are often prescribed for arthritis or skin problems.
• Corticosteroids, such as prednisone, are typically used when SLE affects one or more internal organs.
• Immunosuppressive agents such as azathioprine, methotrexate, cyclophosphamide, cyclosporine and mycophenolate mofetil help control the overactive but misdirected immune system in SLE patients.

THE MI-CP152 STUDY

The MI-CP152 Study is seeking individuals with moderate to severe systemic lupus erythematosus (SLE). The purpose of the MI-CP152 Study is to evaluate the safety and tolerability of an investigational medication in patients diagnosed with severe SLE.

Participation in the MI-CP152 Study includes as may as 24 visits to a local physicians office over a period of up to one year.

Participants will receive study-related medical care at no cost including:

• Study-related health exams
• Lab tests
• Study medication
• Reimbursement for time and travel

Patient Inclusion Criteria = POTENTIAL STUDY VOLUNTEERS MUST:

• Be 18 or older
• Have a diagnosis of systemic lupus erythematosus with at least 4 of the 11 ACR criteria for SLE
• Weigh less than 265 pounds
• Be currently taking 20 mg/day or less of prednisone
• Not have taken the following doses of medication within the last 28 days:
  • Hydroxchloroquine >600 mgs/day
  • Mycophenolate mofetil >3 g/day
  • Methotrexate >25 mg/week
  • Leflunomide >20 mg/day
  • Azathioprine >3 mg/kg/day
  • Cyclophosphamide Any dosage
  • Cyclosporine Any dosage
  • Thalidomide Any dosage
• Not have a history of severe viral infections
• Not have been vaccinated with live attenuated viruses within the last 28 days
• Not have a history of cancer or active tuberculosis

To take part of our Tampa Lupus Clinical Research Study, apply today! For more information, call Clinical Research of West Florida at 813-870-1292 or email us at research@crwf.com.

Consider the following criteria for possible participation in a local clinical research study:

• Men 50 years of age or older
• Women 55 years of age of older
• Diagnosed with gout
• History of major cardiovascular disease (includes stroke, blocked arteries, diabetes)

Qualified participants will receive study medication and study-related medical care at no cost. Compensation for time and travel may also be available for those who qualify.

For more information, call Clinical Research of West Florida at 813-870-1292 or email us at research@crwf.com.